Iliac Vein Stenting and Compression Therapy in Recurrent Venous Ulceration (NCT04834232) | Clinical Trial Compass
UnknownNot Applicable
Iliac Vein Stenting and Compression Therapy in Recurrent Venous Ulceration
Egypt100 participantsStarted 2021-05-01
Plain-language summary
Comparing the result of of iliac vein stenting and compression therapy in management of recurrent venous ulceration.
Who can participate
Age range12 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* iliac vein compression.
* competent superficial venous system.
* isolated iliac vein lesion.
* patent femoropopliteal segment.
* ulcers located in the gaiter area.
* age \> 12 years
* patients with ulcers located in the gaiter area, along with the following associated symptoms: leg heaviness, pain, varicose veins, edema, hemosedrin staining, pruritus, venous dermatitis, lipodermatoscelrosis, telangiectasias, corona phlebectatica, atrophie blanche and deformity of the leg.
Exclusion Criteria:
* patients with arterial disease in the same limb.
* patients with history of phlebitis.
* patients with congenital venous malformation
* patients with malignancy.
* patients with raised renal chemistry.
* patients with skin allergy.
* diabetic neuropathic ulcer.
* atypical site of venous ulcer.
* acute onset DVT.
* age \< 12 years.